Dyskinesias Do Not Develop after Chronic Intermittent Levodopa Therapy in Clinically Hemiparkinsonian Rhesus Monkeys

The stable 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced hemiparkinsonian (HP) rhesus monkey model of Parkinson’s disease (PD) has been frequently used to test preclinical experimental therapeutics targeted to treat patients with advanced PD who suffer from motor fluctuations and drug-...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lieu, Christopher A., Deogaonkar, Milind, Bakay, Roy A. E., Subramanian, Thyagarajan
Formato: Artigo
Lenguaje:Inglês
Publicado: 2010
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3053121/
https://ncbi.nlm.nih.gov/pubmed/21074478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.parkreldis.2010.10.010
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares